278183-71-4Relevant academic research and scientific papers
5-LIPOXYGENASE INHIBITORS
-
Page/Page column 18, (2010/11/29)
The present invention relates to 5-lipoxygenase inhibitors. Compounds disclosed herein can be useful in the treatment of bronchial asthma, chronic obstructive pulmonary disorder, arthritis, type I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, urticaria, atopic dermatitis, allergic rhinitis, other inflammatory and autoimmune diseases. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as 5-lipoxygenase inhibitors are also provided.
Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
-
Page/Page column 20; 21, (2010/11/28)
The present invention relates to 5-lipoxygenase inhibitors of formula I. Compounds disclosed herein can be useful in the treatment of bronchial asthma, chronic obstructive pulmonary disorder, arthritis, type 1 diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, cancer, pruritis, urticaria, atopic dermatitis, allergic rhinitis, other inflammatory and autoimmune diseases. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as 5-lipoxygenase inhibitors are also provided.
Process for preparing 5-lipoxygenase inhibitors
-
, (2008/06/13)
The present invention relates to the process for preparing a compound of the formula wherein A is C1-C6alkyl, an aryl which is mono or disubstituted with F, Cl, Br, OCH3, C1-C3alkyl or benzy. In the p
Process and intermediates for preparing 5-lipoxygenase inhibitors
-
, (2008/06/13)
The present invention relates to the process for preparing a compound of the formula ???wherein A is C1-C6 alkyl, an aryl which is mono or disubstituted with F, Cl , Br,, OCH3, C1-C3 alkyl or benzy. I
